EICHOR
● Completed
Next Generation Rocklatan
Condition: Open Angle Glaucoma · Ocular Hypertension · Sponsor: Alcon Research
About this study
The purpose of this two-stage clinical trial is to assess the safety and hypotensive efficacy of AR-17043 and PG043 ophthalmic solutions in subjects with open-angle glaucoma (OAG) or ocular hypertension (OHT).
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (12)
| Orange County Ophthalmology Medical Group | Garden Grove, California, United States | — |
| United Medical Research Institute | Inglewood, California, United States | — |
| Eye Research Foundation | Newport Beach, California, United States | — |
| North Bay Eye Associates | Petaluma, California, United States | — |
| Eye Center of Northern Colorado, PC | Fort Collins, Colorado, United States | — |
| Coastal Research Associates | Roswell, Georgia, United States | — |
| Rochester Ophthalmological Group | Rochester, New York, United States | — |
| James D. Branch Ophthalmology | Winston-Salem, North Carolina, United States | — |
| Scott & Christie and Associates, PC | Cranberry Township, Pennsylvania, United States | — |
| University Eye Specialists | Maryville, Tennessee, United States | — |
| Total Eye Care PA | Memphis, Tennessee, United States | — |
| Piedmont Eye Center | Lynchburg, Virginia, United States | — |
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06441643